Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the TRIUMPH registrational clinical trials
作者
K. Giblin,Lee M. Kaplan,Virend K. Somers,Carel W. le Roux,David J. Hunter,Qiwei Wu,Amy Lalonde,Nadia Ahmad,M. Angelyn Bethel
By recruiting participants with shared disease exposures, the TRIUMPH program will assess the safety and efficacy of retatrutide for the treatment of adults with obesity and two of its common complications-OSA and OA.